Title : Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases.

Pub. Date : 2020

PMID : 32351894






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases. apatinib epidermal growth factor receptor Homo sapiens
2 We report a case of EGFR wild-type and ALK-negative lung adenocarcinoma patient with multiple symptomatic BMs, who received apatinib together with brain radiation therapy. apatinib epidermal growth factor receptor Homo sapiens